Publication date: 25th July 2016
Processes in development, cancer, and wound healing are determined by the rigidity and ligand density of the extracellular matrix (ECM). ECM rigidity and ligand density are first probed and detected via integrins, transmembrane proteins that link the ECM to the actin cytoskeleton. Current understanding establishes an upper limit of 70nm spacing between integrins bound to ligands on glass surfaces for appropriate clustering and subsequent formation of focal adhesions (FAs). However, the mechanism behind this limit, and its regulation by rigidity, remain largely unknown. Here, we developed a tunable rigidity substrate with controllable ligand spacing and distribution at the nanometer scale. In response to rigidity, we counterintuitively found that FA growth in breast myoepithelial cells was favored as ligand spacing increased from 50 to 100nm. In addition, disordering the distribution of ligands while keeping their density and average spacing constant triggered FA growth at lower rigidities and drastically increased their length. Further, we found that FAs collapse by decreasing their length above a rigidity threshold. Combined with measurements of traction forces and actin flows, these results match qualitatively with a molecular clutch model. This model predicts that substrate rigidity and ligand density affect adhesion formation by regulating integrin-ECM bond force loading, which in turn controls mechanosensing events. Taken together, our findings suggest a force-dependent mechanism which explains FA formation, growth and possibly collapse in response to rigidity and ligand density